WBA they always announce the granting of a patent as l think they should.
The only one granted and not announced that l am aware of is for Dep Insulin which was applied for in 2015 and granted in August 2020. At the time l was (and still am) of the opinion that the reason behind the non disclosure was because it is tied up with one of our undisclosed partners.
The global market for Insulin is in excess of $40 B annually. Improved versions could be a blockbuster of proportions rarely seen.
Ann: US patent issued for DEP cabazitaxel nanoparticle, page-22
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |